1971
DOI: 10.1097/00132586-197112000-00008
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Glucagon Infusion on Cardiovascular Function in the Critically Ill

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1975
1975
1985
1985

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Kinin activation may sustain both the vascular changes and the impairment in 02 extraction. The infusion of bradikinin into an isolated perfused limb produced a reduction in vascular tone as well as a lowering in O2 consumption [29].…”
Section: Discussionmentioning
confidence: 97%
“…Kinin activation may sustain both the vascular changes and the impairment in 02 extraction. The infusion of bradikinin into an isolated perfused limb produced a reduction in vascular tone as well as a lowering in O2 consumption [29].…”
Section: Discussionmentioning
confidence: 97%
“…Large doses of exogenous glucagon exert positive inotropic and chronotropic effects on the heart. [18][19][20][21] In humans, glucagon's inotropic effects are more pronounced than its chronotropic effects, an advantage that minimizes myocardial oxygen consumption and irritability. 18,20 Glucagon increases the movement of calcium ions into myocardial cells 22 and increases intracellular cyclic adenosine monophosphate (cAMP) levels.…”
Section: Glucagonmentioning
confidence: 99%
“…25 Glucagon's cardiotonic effects are additive to that of beta-adrenergic agonists such as dopamine, epinephrine, and isoproterenol. 21,23 Glucagon has been used effectively in the treatment of heart failure and cardiogenic shock 20,[26][27][28] (Table 5). Its major advantages include its synergism with beta-adrenergic agonists and its low dysrhythmogenic properties.…”
Section: Glucagonmentioning
confidence: 99%
“…The polypeptide hormone, glucagon, has been reported to possess a marked positive inotropic effect on isolated cardiac muscle (Farah and Tuttle, 1960;Glick et al, 1968;Lucchesi, 1968), in intact animals (Glick et al, 1968;Lucchesi, 1968) and in patients with impaired cardiac function (Brogan et al, 1969;Vaughn et al, 1970;Wilcken and Lvoff, 1970;Siegel et al, 1970;Lvoff and Wilcken, 1972). There is some uncertainty, however, concerning the effectiveness of glucagon in the management of patients with chronic cardiac decom-pensation (Williams et al, 1969;Greenberg et al, 1970;Smithen et al, 1972).…”
Section: Introductionmentioning
confidence: 99%